Zurcher Kantonalbank »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Zurcher Kantonalbank

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Zurcher Kantonalbank from 13F filings

Historical chart of Zurcher Kantonalbank investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Zurcher Kantonalbank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Zurcher Kantonalbank

Quarter filed Position value Share count Share price at filing
2024-03-31 $756k 650k 1.16
2023-12-31 $759k 750k 1.01
2023-09-30 $845k 750k 1.13

More positions owned by Zurcher Kantonalbank

Microsoft Corporation (MSFT)
Ubs Group SHS (UBS)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alcon Ord Shs (ALC)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Visa Com Cl A (V)
Alphabet Cap Stk Cl C (GOOG)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Linde SHS (LIN)

View all positions for Zurcher Kantonalbank

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Wolverine Asset Management
Calamos Advisors
Braidwell
Highbridge Capital Management
Davidson Kempner Capital Management
Readystate Asset Management
Bank of America Corporation
Lazard Asset Management
Tenor Capital Management
D. E. Shaw & Co
Bank Of Montreal
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Steelhead Partners
Capstone Investment Advisors
Weiss Asset Management LP[1

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1